Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
<h4>Background</h4>The change of malaria case-management policy in Kenya to recommend universal parasitological diagnosis and targeted treatment with artemether-lumefantrine (AL) is supported with activities aiming by 2013 at universal coverage and adherence to the recommendations. We ev...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/adfbdd9218a1489a88eb00971ee70c38 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:adfbdd9218a1489a88eb00971ee70c38 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:adfbdd9218a1489a88eb00971ee70c382021-11-04T06:08:36ZMalaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.1932-620310.1371/journal.pone.0024781https://doaj.org/article/adfbdd9218a1489a88eb00971ee70c382011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21935464/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The change of malaria case-management policy in Kenya to recommend universal parasitological diagnosis and targeted treatment with artemether-lumefantrine (AL) is supported with activities aiming by 2013 at universal coverage and adherence to the recommendations. We evaluated changes in health systems and case-management indicators between the baseline survey undertaken before implementation of the policy and the follow-up survey following the first year of the implementation activities.<h4>Methods/findings</h4>National, cross-sectional surveys using quality-of-care methods were undertaken at public facilities. Baseline and follow-up surveys respectively included 174 and 176 facilities, 224 and 237 health workers, and 2,405 and 1,456 febrile patients. Health systems indicators showed variable changes between surveys: AL stock-out (27% to 21%; p = 0.152); availability of diagnostics (55% to 58%; p = 0.600); training on the new policy (0 to 22%; p = 0.001); exposure to supervision (18% to 13%; p = 0.156) and access to guidelines (0 to 6%; p = 0.001). At all facilities, there was an increase among patients tested for malaria (24% vs 31%; p = 0.090) and those who were both tested and treated according to test result (16% to 22%; p = 0.048). At facilities with AL and malaria diagnostics, testing increased from 43% to 50% (p = 0.196) while patients who were both, tested and treated according to test result, increased from 28% to 36% (p = 0.114). Treatment adherence improved for test positive patients from 83% to 90% (p = 0.150) and for test negative patients from 47% to 56% (p = 0.227). No association was found between testing and exposure to training, supervision and guidelines, however, testing was significantly associated with facility ownership, type of testing, and patients' caseload, age and clinical presentation.<h4>Conclusions</h4>Most of the case-management indicators have shown some improvement trends; however differences were smaller than expected, rarely statistically significant and still leaving a substantial gap towards optimistic targets. The quantitative and qualitative improvement of interventions will ultimately determine the success of the new policy.Andrew NyandigisiDorothy MemusiAgneta MbithiNewton Ang'waMildred ShieshiaAlex MuturiRaymond SudoiSophie GithinjiElizabeth JumaDejan ZurovacPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 9, p e24781 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Andrew Nyandigisi Dorothy Memusi Agneta Mbithi Newton Ang'wa Mildred Shieshia Alex Muturi Raymond Sudoi Sophie Githinji Elizabeth Juma Dejan Zurovac Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| description |
<h4>Background</h4>The change of malaria case-management policy in Kenya to recommend universal parasitological diagnosis and targeted treatment with artemether-lumefantrine (AL) is supported with activities aiming by 2013 at universal coverage and adherence to the recommendations. We evaluated changes in health systems and case-management indicators between the baseline survey undertaken before implementation of the policy and the follow-up survey following the first year of the implementation activities.<h4>Methods/findings</h4>National, cross-sectional surveys using quality-of-care methods were undertaken at public facilities. Baseline and follow-up surveys respectively included 174 and 176 facilities, 224 and 237 health workers, and 2,405 and 1,456 febrile patients. Health systems indicators showed variable changes between surveys: AL stock-out (27% to 21%; p = 0.152); availability of diagnostics (55% to 58%; p = 0.600); training on the new policy (0 to 22%; p = 0.001); exposure to supervision (18% to 13%; p = 0.156) and access to guidelines (0 to 6%; p = 0.001). At all facilities, there was an increase among patients tested for malaria (24% vs 31%; p = 0.090) and those who were both tested and treated according to test result (16% to 22%; p = 0.048). At facilities with AL and malaria diagnostics, testing increased from 43% to 50% (p = 0.196) while patients who were both, tested and treated according to test result, increased from 28% to 36% (p = 0.114). Treatment adherence improved for test positive patients from 83% to 90% (p = 0.150) and for test negative patients from 47% to 56% (p = 0.227). No association was found between testing and exposure to training, supervision and guidelines, however, testing was significantly associated with facility ownership, type of testing, and patients' caseload, age and clinical presentation.<h4>Conclusions</h4>Most of the case-management indicators have shown some improvement trends; however differences were smaller than expected, rarely statistically significant and still leaving a substantial gap towards optimistic targets. The quantitative and qualitative improvement of interventions will ultimately determine the success of the new policy. |
| format |
article |
| author |
Andrew Nyandigisi Dorothy Memusi Agneta Mbithi Newton Ang'wa Mildred Shieshia Alex Muturi Raymond Sudoi Sophie Githinji Elizabeth Juma Dejan Zurovac |
| author_facet |
Andrew Nyandigisi Dorothy Memusi Agneta Mbithi Newton Ang'wa Mildred Shieshia Alex Muturi Raymond Sudoi Sophie Githinji Elizabeth Juma Dejan Zurovac |
| author_sort |
Andrew Nyandigisi |
| title |
Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| title_short |
Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| title_full |
Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| title_fullStr |
Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| title_full_unstemmed |
Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. |
| title_sort |
malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in kenya. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/adfbdd9218a1489a88eb00971ee70c38 |
| work_keys_str_mv |
AT andrewnyandigisi malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT dorothymemusi malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT agnetambithi malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT newtonangwa malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT mildredshieshia malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT alexmuturi malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT raymondsudoi malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT sophiegithinji malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT elizabethjuma malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya AT dejanzurovac malariacasemanagementfollowingchangeofpolicytouniversalparasitologicaldiagnosisandtargetedartemisininbasedcombinationtherapyinkenya |
| _version_ |
1718445169934598144 |